BioStock Investor Meeting, September 14
On September 14, we arranged the BioStock Investor Meeting, where life science companies from various therapeutic areas presented their activities to investors and potential partners. The event was held in front of a live audience, but you may access the recorded presentations via the links below.
At the BioStock Investor Meeting, investors, analysts and stakeholders had the chance to listen to – and mingle with – companies in the Nordic life science sector on site in central Stockholm.
The program included eleven companies from a wide range of therapeutic areas and indications. In addition, we got to listen to Mattias Häggblom, Equity Research Analyst and Sector Head for Nordic life science stocks at Handelsbanken, who talked about the conditions on the stock market as well as for Nordic life science projects in general.
Program and video presentations
Below, you may find the full program from the BioStock Investor Meeting on September 14, 2022, including links to each presentation.
- 9:00-10:00 Registration & breakfast
- 10:00 Pharmiva, presented by CEO Anna Linton
- 10:20 Redwood Pharma, presented by CEO Martin Vidaeus
- 10:40 Key Note: Mattias Häggblom, Handelsbanken
- 11:00 Paus
- 11:20 Elicera Therapeutics, presented by CEO Jamal El-Mosleh
- 11:40 WntResearch, presented by CEO Pernilla Sandwall
- 12:00 Lipum, presented by CEO Einar Pontén
- 12:20 Lunch
- 13:00 Cereno Scientific, presented by CEO Sten R. Sörensen (and CMO Björn Dahlöf)
- 13:20 Arcede Pharma, presented by CEO Mia Lundblad
- 13:40 Cyxone, presented by interim CEO Carl-Magnus HögerKorp
- 14:00 Paus
- 14:20 Idogen, presented by interim CEO Christina Herder
- 14:40 Brain+, presented by CEO Kim Baden-Kristensen
- 15:00 OssDsign, presented by CFO Anders Svensson
Interviews
In connection with the BioStock Investor Meeting on September 14, 2022, BioStock took the opportunity to chat with the representatives from each of the presenting companies. Watch the interviews via the links below, listed alphabetically by company name.
- Arcede Pharma – interview with CEO Mia Lundblad
- Brain+ – interview with CEO Kim Baden-Kristensen
- Cereno Scientific – interview with CEO Sten R. Sörensen
- Cyxone – interview with interim CEO Carl-Magnus HögerKorp
- Elicera Therapeutics – interview with CEO Jamal El-Mosleh
- Idogen – interview with interim CEO Christina Herder
- Lipum – interview with CEO Einar Pontén
- OssDsign – interview with CFO Anders Svensson
- Pharmiva – interview with CEO Anna Linton
- Redwood Pharma – interview with CEO Martin Vidaeus
- WntResearch – interview with CEO Pernilla Sandwall
Upcoming events
You can read more about BioStock’s other 2022 events via the links below. Next up is our flagship event the BioStock Life Science Summit held at Medicon Village in Lund 29-30 November – see you there!
